Analysts see little effect on the bottom lines of biopharma companies, as they stand to stave off tariff pressure and receive ...

The clearance is the first in Cytokinetics’ lengthy history and pits its drug Myqorzo against Bristol Myers’ Camzyos, which ...

The startup’s filing comes during a broader biotech recovery that’s made some industry watchers optimistic IPOs could rebound ...

The clearance brings an oral form of Novo’s Wegovy to market ahead of Lilly’s rival medication and kicks off the next phase ...

The overall leadership outlook was positive in a recent survey but varied between executives in the U.S. and those overseas.

Two pilot programs would tie Medicare costs and rebates in the U.S. to what’s paid in comparable countries. Elsewhere, AstraZeneca reported a setback and an “off the shelf” cell therapy showed promise ...

Michelle McMurry-Heath, the CEO of the Biotechnology Innovation Organization, has stepped down from her position running the industry association amid reported disagreements between members over the ...

The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a ...

Recognizing the urgent need for treatment options and guided by patient insights, Pfizer scientists have discovered a way to decrease the level of GDF-15 circulating in the body in order to ...

The financing follows a strategic shift for Orum, which shelved its original lead program and is now pursuing a potential ...